FLT3 and acute myeloid leukemia: The co-occurrence of NPM1 mutation and FLT3-TKD mutation defines an AML subgroup exhibiting a highly favorable prognostic profile compared to NPM1-mutated AMLs without FLT3-TKD mutation [59].